KRAS and colorectal carcinoma: Serrated polyps are primarily distinguished by BRAF and/or KRAS genetic mutations, coupled with epigenetic alterations in the CpG island methylator phenotype (CIMP), collaborating to initiate and propel malignant transformation from normal colon mucosa to polyps and ultimately to CRC [15].